Source: Eur Respir J 2005; 25: 402-405



Rating:

Share or cite this content

Citations should be made in the following way:
Bryant D. H.. Obliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated?. Eur Respir J 2005; 25: 402-405

Member's Comments

No comment yet.

Related content which might interest you: Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation Source: Eur Respir J 2011; 38: 470-472 Year: 2011 Bronchiolitis obliterans following haematopoietic stem cell transplantation Source: Eur Respir J 2007; 29: 1007-1019 Year: 2007 Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation Source: International Congress 2016 – Orphan diseases II Year: 2016 Long term azithromycin use for bronchiolitis obliterans in ten allogeneic hematopoietic stem cell transplant recipients Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous Year: 2008 Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation Source: Eur Respir J 2004; 23: 440-445 Year: 2004 Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation Source: Eur Respir J, 51 (5) 1702617; 10.1183/13993003.02617-2017 Year: 2018 Noninfectious pulmonary complications of haematopoietic stem cell transplantation Source: Eur Respir Rev, 29 (156) 190119; 10.1183/16000617.0119-2019 Year: 2020 Home spirometry in bronchiolitis obliterans after allogeneic haematopoietic cell transplant Source: Eur Respir J, 52 (1) 1702328; 10.1183/13993003.02328-2017 Year: 2018 Pulmonary infiltrates in allogenic hematopoietic stem cell transplantation recipients Source: Eur Respir J 2002; 20: Suppl. 38, 476s Year: 2002 Long term follow-up of patients with Bronchiolitis obliterans Syndrome after hematopoietic stem cell transplantation Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans Year: 2019 Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation Source: Eur Respir J 2014; 43: 221-232 Year: 2004 Updated prevalence and risk factors for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation. Source: International Congress 2018 – The importance of the pulmonary function test in different clinical settings Year: 2018 Influence of respiratory viruses on airflow decline after allogenic hematopoietic stem cell transplantation Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016 Lung transplantation after allogeneic stem cell transplantation: a pan-European experience Source: Eur Respir J, 51 (2) 1701330; 10.1183/13993003.01330-2017 Year: 2018 Restrictive chronic lung function decline after haematopoietic stem cell transplantation Source: Eur Respir J 2016; 47: 336-339 Year: 2016 Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT) Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Lung biopsy predicts outcome in bronchiolitis obliterans following allogeneic stemcell transplantation Source: Annual Congress 2011 - General thoracic surgery I Year: 2011 Pulmonary function in very long-term survivors after allogeneic stem cell transplantation (aSCT) Source: International Congress 2018 – New insights in testing lung and respiratory muscle functions Year: 2018 Effect of extracorporeal photopheresis on respiratory function in hematopoietic stem cell transplant recipients Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 Sarcoidosis in donor-derived tissues after haematopoietic stem cell transplantation Source: Eur Respir J 2013; 41: 1452-1453 Year: 2013